SCHEMBL6702897

SCHEMBL6702897

O=C1C=C(c2ccccc2)C(C(=O)O)O1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.42
LMNA P02545 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CFTR P13569 1/20 0.36
GOPC Q9HD26 1/20 0.36
CASP6 P55212 1/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ADORA3 P0DMS8 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
HSD17B10 Q99714 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
TP53 P04637 1/20 0.32
PTPN1 P18031 1/20 0.32
PTPN11 Q06124 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5261044 0.77 LMNA (0.44) POLBLMNAMEN1KMT2ACFTR
SCHEMBL29221193 0.74 APEX1 (0.44) POLBLMNAMEN1KMT2ACFTR
SCHEMBL3219657 0.73 POLB (0.44) POLBLMNAMEN1KMT2ACFTR
SCHEMBL1697379 0.72 KMT2A (0.51) POLBLMNAMEN1KMT2ACFTR
SCHEMBL10481123 0.71 KDM4E (0.56) POLBLMNAMEN1KMT2AKDM4E
SCHEMBL31474039 0.67 CFTR (0.36) LMNAMEN1KMT2ACFTRGOPC
SCHEMBL9257799 0.65 CA12 (0.38) POLBLMNAMEN1KMT2A
SCHEMBL9270616 0.65 APP (0.38) POLBLMNAMEN1KMT2AKDM4E
SCHEMBL11530324 0.63 POLB (0.41) POLBLMNAMEN1KMT2ACASP6
Biphenyl SCHEMBL10797777 0.62 ALDH1A1 (0.64) LMNAALDH1A1SMN1; SMN2L3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040102488-A1 Butenolide and pentenolide derivatives as kinase inhibitors MORPHOCHEM AG (DE) 2004-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102488-A1 Butenolide and pentenolide derivatives as kinase inhibitors MAP3K20, MAP3K21, MAP3K1 POLB 3185/4885LMNA 791/4885MEN1 2347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.